Tag Archives: FSE: Feline Spongiform Encephalopathy

Minimising CJD and vCJD Transmission Risks in Healthcare and Community Settings (Department of Health)

Posted on July 17, 2015 by Dementia and Elderly Care News

Summary The Advisory Committee on Dangerous Pathogens’ Transmissible Spongiform Encephalopathy (ACDP TSE) Risk Management Subgroup has released updated guidance which aims to minimise the risks of transmission of CJD and vCJD in healthcare and other public settings. Full Text Link … Continue reading →

Posted in Acute Hospitals, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, Local Interest, Management of Condition, National, NHS, Person-Centred Care, Practical Advice, Quick Insights, Standards, UK, Universal Interest | Tagged Abnormal Proteins (Prions), ACDP TSE Ophthalmic Sub-Group, Advisory Committee on Dangerous Pathogens, Advisory Committee on Dangerous Pathogens (ACDP), Advisory Committee on Dangerous Pathogens (ACDP) Transmissible Spongiform Encephalopathy (TSE) Sub Group, Advisory Committee on Dangerous Pathogens. Transmissible Spongiform Encephalopathy Agents: Alert for Urological Surgeons Regarding Equipment Used for Patients At Risk of vCJD (Transrectal Prostatic Bi, Advisory Committee on the Safety of Blood, Advisory Committee on the Safety of Blood Tissues and Organs (SaBTO), Anaesthesia and Intensive Care, Association of Anaesthetists of Great Britain and Ireland (AAGBI), Bed Linen, Blood Organ and Tissue Donation, Blood Safety, Blood Transfusions, Bovine Spongiform Encephalopathy (BSE), Childbirth, CJD, CJD and vCJD Transmission Precautions, CJD and vCJD Transmission Routes, CJD Guidance For Ophthalmologists, CJD Risk Management, CJD Surveillance, Clinical Waste, Community Healthcare of CJD Patients, Contaminated Surgical Instruments, COSHH: Control of Substances Hazardous to Health Regulations 2002, Creutzfeldt-Jakob Disease (CJD), Creuzfeldt Jacob Disease (CJD), Decontamination of Surgical Instruments, Dental Instruments, Dentistry, Distribution of Transmissible Spongiform Encephalopathy Infectivity in Human Tissues and Body Fluids, Donor Blood, Engineering and Science Advisory Committee Into the Decontamination of Surgical Instruments Including Prion Removal (ESAC-Pr), Enhanced Surveillance: At Risk Individuals, FFI: Fatal Familial Insomnia, FSE: Feline Spongiform Encephalopathy, GSS: Gerstmann Sträussler Scheinker Disease, Guidelines for Handling Tissues From Patients With or At Risk of CJD or vCJD, Haematology, Haemovigilance, Health and Safety Management of Transmissible Spongiform Encephalopathy, HGH: Human Growth Hormone, Hospital Care of CJD Patients, Infection and Infectious Diseases, Infection Control of CJD vCJD and Other Human Prion Diseases in Healthcare and Community Settings, Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC), Mad Cow Disease, Management of Instruments and Tissues From Brain Biopsy Procedures on Patients With Progressive Neurological Disorders, MBM: Meat and Bone Meal, Medical Instruments, Medical Procedures, Minimising CJD and vCJD Transmission Risks, Neurodegenerative Diseases, NHS Blood and Transplant (NHSBT), Novel Pathogens, Occupational Exposure, Parliament, Pathogens, Pregnancy, Public Health, Royal College of Ophthalmologists and the Advisory Committee on Dangerous Pathogens TSE Working Group: CJD Guidance For Ophthalmologists, Safe Working and the Prevention of Infection: Laboratory Containment and Control Measures, SBO: Specified Bovine Offal, Spillages, Standing Advisory Committee for Transfusion Transmitted Infections, Surgical Transmission of Prions, Surveillance, Tissues and Organs (SaBTO), TME: Transmissible Mink Encephalopathy, Transfusion-Transmitted Infection, Transmissible Spongiform Encephalopathies: Diagnostic Criteria, Transmissible Spongiform Encephalopathies: Distribution of Infectivity in Animal Tissue and Body Fluids, Transmissible Spongiform Encephalopathy (ACDP TSE) Risk Management Subgroup, Transmissible Spongiform Encephalopathy Agents, Transmissible Spongiform Encephalopathy Agents: Abbreviations, Transmissible Spongiform Encephalopathy Agents: After Death, Transmissible Spongiform Encephalopathy Agents: Assessment Before Surgery and or Endoscopy to Identify Patients With or At Risk of CJD or vCJD, Transmissible Spongiform Encephalopathy Agents: Endoscopy, Transmissible Spongiform Encephalopathy Agents: Frequently Asked Questions, Transmissible Spongiform Encephalopathy Agents: General Principles of Decontamination and Waste Disposal, Transmissible Spongiform Encephalopathy Agents: Guidelines for Pathologists and Pathology Laboratories, Transmissible Spongiform Encephalopathy Agents: Information Sheet for Funeral Directors Relatives and Others Following a CJD Death, Transmissible Spongiform Encephalopathy Agents: Managing CJD or vCJD Risk in Ophthalmology, Transmissible Spongiform Encephalopathy Agents: Managing vCJD Risk in General Surgery and Liver Transplantation, Transmissible Spongiform Encephalopathy Agents: Quarantining of Surgical Instruments, Transmissible Spongiform Encephalopathy Agents: Safe Working and the Prevention of Infection, Transmissible Spongiform Encephalopathy Agents: Transport of Transmissible Spongiform Encephalopathy-Infected Material, Transport of Transmissible Spongiform Encephalopathy-Infected Material, TSE Risk Assessment Subgroup of the Advisory Committee on Dangerous Pathogens, UK Blood Safety, UK Blood Services, UK Blood Services Joint Professional Advisory Committee, UK Blood Supply, Variant CJD and Blood, Variant Creutzfeldt-Jakob Disease, vCJD Blood Testing, vCJD Carriers in UK, vCJD Infection | Leave a comment